From today, Mounjaro prescriptions will be accessible at GP surgeries across England, but only for patients who meet stringent eligibility criteria. This gradual introduction aims to prioritize individuals with significant health risks due to obesity, alongside managing healthcare resources. Mounjaro, initially approved for type 2 diabetes treatment, is also effective for weight loss. The first patients to receive the drug will include those with a high BMI and various related health conditions. Their care will also include additional support for lifestyle changes to enhance treatment outcomes.
Prescriptions for Mounjaro will be available at GP surgeries in England, but only for patients meeting strict criteria, aiming to prioritize the most in need.
NHS England emphasizes a staggered approach for Mounjaro prescriptions to manage resources effectively and ensure those most at need are prioritized.
Collection
[
|
...
]